Artiva Biotherapeutics, Inc. (ARTV)
10.22
-0.20
(-1.92%)
USD |
NASDAQ |
Sep 11, 16:00
10.23
+0.01
(+0.10%)
After-Hours: 20:00
Artiva Biotherapeutics Total Assets (Quarterly) : 368.63M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 368.63M |
| March 31, 2026 | 105.96M |
| December 31, 2025 | 134.57M |
| September 30, 2025 | 148.86M |
| June 30, 2025 | 169.39M |
| March 31, 2025 | 191.26M |
| December 31, 2024 | 209.58M |
| September 30, 2024 | 225.60M |
| June 30, 2024 | 75.91M |
| March 31, 2024 | 90.16M |
| December 31, 2023 | 105.11M |
| September 30, 2023 |
| Date | Value |
|---|---|
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 161.83M |
| December 31, 2021 | 169.93M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 29.23M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Climb Bio, Inc. | 246.29M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.13M |
| Shareholders Equity (Quarterly) | 347.50M |
| Debt to Equity Ratio | 0.0283 |
| Current Ratio | 24.16 |
| Net Debt Paydown Yield | 0.18% |